Option Care Health released FY2025 Q1 earnings on April 29 Pre-Market EST, actual revenue USD 1.333 B (forecast USD 1.257 B), actual EPS USD 0.28 (forecast USD 0.2712)

Brief Summary

Option Care Health reported Q1 2025 earnings with revenue of $1.333 billion and EPS of $0.28, exceeding market expectations of $1.257 billion and $0.2712 respectively LB filings.

Impact of The News

Option Care Health’s Q1 2025 results demonstrate strong performance with revenue and EPS both surpassing market expectations. The company achieved a 16.3% increase in revenue from the previous year, highlighting robust growth in its business operations LB filings+ 2. It reported a net profit of $46.74 million, improving from $44.8 million in Q1 2024, indicating enhanced profitability Reuters.

Compared to industry benchmarks, its EPS of $0.28 is above the consensus of $0.2712, though slightly below the average analyst expectation of $0.30 Reuters. The company’s EBITDA of $93.56 million also surpassed expectations, suggesting effective cost management and operational efficiency LB filings.

Looking forward, Option Care Health projects significant growth for the full year 2025, estimating revenue between $5.4 billion and $5.6 billion and adjusted EPS between $1.61 and $1.70, both above market expectations . These projections indicate confidence in continued expansion and profitability, potentially driven by increased demand for infusion services and strategic investments in business development .